123 related articles for article (PubMed ID: 21406231)
1. Preventive and therapeutic types of environmental enrichment counteract beta amyloid pathology by different molecular mechanisms.
Herring A; Lewejohann L; Panzer AL; Donath A; Kröll O; Sachser N; Paulus W; Keyvani K
Neurobiol Dis; 2011 Jun; 42(3):530-8. PubMed ID: 21406231
[TBL] [Abstract][Full Text] [Related]
2. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Aβ deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease.
Kameshima N; Nanjou T; Fukuhara T; Yanagisawa D; Tooyama I
Neurosci Lett; 2012 Apr; 513(2):166-9. PubMed ID: 22343315
[TBL] [Abstract][Full Text] [Related]
4. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
[TBL] [Abstract][Full Text] [Related]
5. Efficient near-infrared in vivo imaging of amyoid-β deposits in Alzheimer's disease mouse models.
Schmidt A; Pahnke J
J Alzheimers Dis; 2012; 30(3):651-64. PubMed ID: 22460331
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease.
Amtul Z; Wang L; Westaway D; Rozmahel RF
Neuroscience; 2010 Aug; 169(2):781-6. PubMed ID: 20493928
[TBL] [Abstract][Full Text] [Related]
7. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease.
Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM
Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.
Blanchard J; Wanka L; Tung YC; Cárdenas-Aguayo Mdel C; LaFerla FM; Iqbal K; Grundke-Iqbal I
Acta Neuropathol; 2010 Nov; 120(5):605-21. PubMed ID: 20697724
[TBL] [Abstract][Full Text] [Related]
9. Lipid oxidation and modification of amyloid-β (Aβ) in vitro and in vivo.
Ellis G; Fang E; Maheshwari M; Roltsch E; Holcomb L; Zimmer D; Martinez D; Murray IV
J Alzheimers Dis; 2010; 22(2):593-607. PubMed ID: 20847409
[TBL] [Abstract][Full Text] [Related]
10. Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease.
Hemming ML; Patterson M; Reske-Nielsen C; Lin L; Isacson O; Selkoe DJ
PLoS Med; 2007 Aug; 4(8):e262. PubMed ID: 17760499
[TBL] [Abstract][Full Text] [Related]
11. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease.
Wang J; Ho L; Qin W; Rocher AB; Seror I; Humala N; Maniar K; Dolios G; Wang R; Hof PR; Pasinetti GM
FASEB J; 2005 Apr; 19(6):659-61. PubMed ID: 15650008
[TBL] [Abstract][Full Text] [Related]
12. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice.
Lazarov O; Robinson J; Tang YP; Hairston IS; Korade-Mirnics Z; Lee VM; Hersh LB; Sapolsky RM; Mirnics K; Sisodia SS
Cell; 2005 Mar; 120(5):701-13. PubMed ID: 15766532
[TBL] [Abstract][Full Text] [Related]
13. Aβ secretion and plaque formation depend on autophagy.
Nilsson P; Loganathan K; Sekiguchi M; Matsuba Y; Hui K; Tsubuki S; Tanaka M; Iwata N; Saito T; Saido TC
Cell Rep; 2013 Oct; 5(1):61-9. PubMed ID: 24095740
[TBL] [Abstract][Full Text] [Related]
14. Do amyloid β-associated factors co-deposit with Aβ in mouse models for Alzheimer's disease?
Timmer NM; Kuiperij HB; de Waal RM; Verbeek MM
J Alzheimers Dis; 2010; 22(2):345-55. PubMed ID: 20847441
[TBL] [Abstract][Full Text] [Related]
15. Enoxaparin treatment administered at both early and late stages of amyloid β deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Aβ levels.
Timmer NM; van Dijk L; van der Zee CE; Kiliaan A; de Waal RM; Verbeek MM
Neurobiol Dis; 2010 Oct; 40(1):340-7. PubMed ID: 20600909
[TBL] [Abstract][Full Text] [Related]
16. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
[TBL] [Abstract][Full Text] [Related]
17. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
[TBL] [Abstract][Full Text] [Related]
19. The molecular pathology of Alzheimer's disease.
Harrington CR
Neuroimaging Clin N Am; 2012 Feb; 22(1):11-22, vii. PubMed ID: 22284730
[TBL] [Abstract][Full Text] [Related]
20. Amyloid pathology in spinal cord of the transgenic Alzheimer's disease mice is correlated to the corticospinal tract pathway.
Yuan Q; Su H; Zhang Y; Chau WH; Ng CT; Song YQ; Huang JD; Wu W; Lin ZX
J Alzheimers Dis; 2013; 35(4):675-85. PubMed ID: 23478304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
